Suppr超能文献

相似文献

1
Deletion of Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma.
Front Microbiol. 2021 Jul 8;12:667968. doi: 10.3389/fmicb.2021.667968. eCollection 2021.
4
Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
Front Immunol. 2020 Mar 3;11:367. doi: 10.3389/fimmu.2020.00367. eCollection 2020.
5
Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas.
Int J Mol Sci. 2018 Apr 12;19(4):1168. doi: 10.3390/ijms19041168.
7
Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01022-18. Print 2018 Dec 1.
8
Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21.
9
From virus to cancer: Epstein-Barr virus miRNA connection in Burkitt's lymphoma.
Infect Agent Cancer. 2024 Oct 18;19(1):54. doi: 10.1186/s13027-024-00615-1.
10
Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1.
J Virol. 2015 Dec;89(23):12178-88. doi: 10.1128/JVI.01757-15. Epub 2015 Sep 23.

引用本文的文献

1
The 'Oma's of the Gammas-Cancerogenesis by γ-Herpesviruses.
Viruses. 2024 Dec 17;16(12):1928. doi: 10.3390/v16121928.
2
Functional Targets for Epstein-Barr Virus BART MicroRNAs in B Cell Lymphomas.
Cancers (Basel). 2024 Oct 19;16(20):3537. doi: 10.3390/cancers16203537.
3
Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers.
Cancers (Basel). 2024 Feb 29;16(5):991. doi: 10.3390/cancers16050991.
4
Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?
Front Oncol. 2023 Jul 17;13:1175545. doi: 10.3389/fonc.2023.1175545. eCollection 2023.
5
Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma.
Life (Basel). 2023 Feb 14;13(2):521. doi: 10.3390/life13020521.
6
Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases.
J Virol. 2022 Jun 22;96(12):e0039422. doi: 10.1128/jvi.00394-22. Epub 2022 May 25.
7
Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.
Viruses. 2021 Nov 23;13(12):2344. doi: 10.3390/v13122344.
8
Modification of EBV-Associated Pathologies and Immune Control by Coinfections.
Front Oncol. 2021 Oct 28;11:756480. doi: 10.3389/fonc.2021.756480. eCollection 2021.

本文引用的文献

1
Role of Epstein-Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma.
Cancers (Basel). 2021 Feb 1;13(3):561. doi: 10.3390/cancers13030561.
3
Deletion of BART miRNA-encoding cluster in Epstein-Barr virus DNA in classic Hodgkin lymphoma.
Pathol Int. 2020 Dec;70(12):1032-1033. doi: 10.1111/pin.13022. Epub 2020 Sep 21.
5
Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
Front Immunol. 2020 Mar 3;11:367. doi: 10.3389/fimmu.2020.00367. eCollection 2020.
6
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma.
Cancer Cell. 2020 Mar 16;37(3):403-419.e6. doi: 10.1016/j.ccell.2020.02.005.
7
Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genes.
Rev Med Virol. 2020 Mar;30(2):e2095. doi: 10.1002/rmv.2095. Epub 2019 Dec 17.
8
Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting.
Leuk Lymphoma. 2020 Apr;61(4):808-819. doi: 10.1080/10428194.2019.1699080. Epub 2019 Dec 13.
9
Latency and lytic replication in Epstein-Barr virus-associated oncogenesis.
Nat Rev Microbiol. 2019 Nov;17(11):691-700. doi: 10.1038/s41579-019-0249-7. Epub 2019 Sep 2.
10
Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验